These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33195829)

  • 41. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Vissing CR; Thomsen C; Vissing J
    Neurology; 2014 Sep; 83(13):1178-83. PubMed ID: 25142899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
    Goselink RJM; Mul K; van Kernebeek CR; Lemmers RJLF; van der Maarel SM; Schreuder THA; Erasmus CE; Padberg GW; Statland JM; Voermans NC; van Engelen BGM
    Neurology; 2019 Jan; 92(4):e378-e385. PubMed ID: 30568007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical and genetical features of Japanese early-onset facioscapulohumeral muscular dystrophy].
    Yamanaka G; Goto K; Hayashi YK; Miyajima T; Hoshika A; Arahata K
    No To Hattatsu; 2002 Jul; 34(4):318-24. PubMed ID: 12134683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
    Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
    Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
    Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
    Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A patient with facioscapulohumeral muscular dystrophy accompanied by myasthenia gravis].
    Sakuma H; Shimazaki S; Saito H; Ohuchi M
    Rinsho Shinkeigaku; 2001; 41(4-5):179-83. PubMed ID: 11676158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Telemedicine for Facio-Scapulo-Humeral Muscular Dystrophy: A multidisciplinary approach to improve quality of life and reduce hospitalization rate?
    Portaro S; Calabrò RS; Bramanti P; Silvestri G; Torrisi M; Conti-Nibali V; Caliri S; Lunetta C; Alagna B; Naro A; Bramanti A
    Disabil Health J; 2018 Apr; 11(2):306-309. PubMed ID: 28967584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
    Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ventilatory support in facioscapulohumeral muscular dystrophy.
    Wohlgemuth M; van der Kooi EL; van Kesteren RG; van der Maarel SM; Padberg GW
    Neurology; 2004 Jul; 63(1):176-8. PubMed ID: 15249635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle.
    Laoudj-Chenivesse D; Carnac G; Bisbal C; Hugon G; Bouillot S; Desnuelle C; Vassetzky Y; Fernandez A
    J Mol Med (Berl); 2005 Mar; 83(3):216-24. PubMed ID: 15551024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1.
    Park HJ; Hong JM; Lee JH; Lee HS; Shin HY; Kim SM; Ki CS; Lee JH; Choi YC
    Neuromuscul Disord; 2015 Nov; 25(11):859-64. PubMed ID: 26319123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
    Su Q; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.
    Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC
    Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Respiratory muscle weakness in facioscapulohumeral muscular dystrophy.
    Henke C; Spiesshoefer J; Kabitz HJ; Herkenrath S; Randerath W; Brix T; Görlich D; Young P; Boentert M
    Muscle Nerve; 2019 Dec; 60(6):679-686. PubMed ID: 31566774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle.
    Campbell AE; Belleville AE; Resnick R; Shadle SC; Tapscott SJ
    Hum Mol Genet; 2018 Aug; 27(R2):R153-R162. PubMed ID: 29718206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy.
    Mariot V; Roche S; Hourdé C; Portilho D; Sacconi S; Puppo F; Duguez S; Rameau P; Caruso N; Delezoide AL; Desnuelle C; Bessières B; Collardeau S; Feasson L; Maisonobe T; Magdinier F; Helmbacher F; Butler-Browne G; Mouly V; Dumonceaux J
    Ann Neurol; 2015 Sep; 78(3):387-400. PubMed ID: 26018399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.